Clinical study of the application value of dispersion mapping in recurrent atrial fibrillation patients after paroxysmal atrial fibrillation ablation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037310

Enrollment

Unknown

Registered

2020-08-27

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

A:Re-PVI + dispersion regional intervention

B:Re-PVI

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The duration of atrial fibrillation is less than 7 days; 2. Age is less than 75 years old; 3. The inner diameter of the left atrium is not more than 45mm; 4. The NYHA cardiac function classification is above grade II.

Exclusion criteria

Exclusion criteria: 1. Fresh thrombus in the left atrium; 2. Aged < 18 years; 3. Heart decompensation; 4. Contraindications to anticoagulation; 5. Atrial fibrillation radiofrequency ablation in the past month.

Design outcomes

Primary

Measure	Time frame
Intraoperative atrial fibrillation termination rate;Intraoperative and postoperative complications;Postoperative atrial fibrillation recurrence rate;	—

Secondary

Measure	Time frame
Evaluation of SF-36 quality of life score 6 months after operation;	—

Countries

China

Contacts

Public ContactShaohui Wu

Shanghai Jiao Tong University, Shanghai Chest Hospital

wushaohui18@163.com+86 158 2196 0839

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026